本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ventyx Biosciences, Inc.

14.00
0.0000
成交量:- -
成交額:7,625.72萬
市值:10.05億
市盈率:-9.34
高:14.00
開:14.00
低:14.00
收:14.00
52周最高:25.00
52周最低:0.7830
股本:7,175.01萬
流通股本:5,355.59萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.4991
每股收益(LYR):-1.9732
淨資產收益率:-45.35%
總資產收益率:-28.47%
市淨率:5.25
市盈率(LYR):-7.10

資料載入中...

2023/05/03

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/05/03

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/04/28

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/04/07

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/03/23

重要事件披露

8-K - Current report
2023/03/23

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/22

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/03/02

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/30

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/01/26

重要事件披露

8-K - Current report
2023/01/12

重要事件披露

8-K - Current report
2023/01/05

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/12/30

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/20

重要事件披露

8-K - Current report
2022/12/16

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/15

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/12

重要事件披露

8-K - Current report
2022/11/30

重要事件披露

8-K - Current report
2022/11/09

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership